These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37649849)

  • 1. Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis.
    Abdel-Razek O; Di Santo P; Jung RG; Parlow S; Motazedian P; Prosperi-Porta G; Visintini S; Marbach JA; Ramirez FD; Simard T; Labinaz M; Mathew R; Hibbert B
    Crit Care Explor; 2023 Sep; 5(9):e0962. PubMed ID: 37649849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
    Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
    Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes Between Milrinone and Dobutamine in Patients With Cardiogenic Shock: A Meta-Analysis of Randomized Control Trials and Observational Studies.
    Fan C; Wei CR; Ali N
    Cureus; 2024 Feb; 16(2):e54948. PubMed ID: 38544600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Inotropes on the Mortality in Patients With Septic Shock.
    Sato R; Ariyoshi N; Hasegawa D; Crossey E; Hamahata N; Ishihara T; Nasu M; Devendra G
    J Intensive Care Med; 2021 Feb; 36(2):211-219. PubMed ID: 31793373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
    Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury.
    Di Santo P; Dehghan K; Mao B; Jung RG; Fadare D; Paydar J; Parlow S; Motazedian P; Prosperi-Porta G; Abdel-Razek O; Joseph J; Goh CY; Chung K; Mulloy A; Ramirez FD; Simard T; Hibbert B; Mathew R; Russo JJ
    JACC Adv; 2023 Jul; 2(5):100393. PubMed ID: 38938997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
    N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
    Jung RG; Di Santo P; Mathew R; Simard T; Parlow S; Weng W; Abdel-Razek O; Malhotra N; Cheung M; Hutson JH; Marbach JA; Motazedian P; Thibert MJ; Fernando SM; Nery PB; Nair GM; Russo JJ; Hibbert B; Ramirez FD
    Can J Cardiol; 2023 Apr; 39(4):394-402. PubMed ID: 36150583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
    Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
    ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support.
    Nandkeolyar S; Doctorian T; Fraser G; Ryu R; Fearon C; Tryon D; Kagabo W; Abramov D; Hauschild C; Stoletniy L; Hilliard A; Sakr A
    Clin Med Insights Cardiol; 2021; 15():11795468211049449. PubMed ID: 34720602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
    Parlow S; Di Santo P; Mathew R; Jung RG; Simard T; Gillmore T; Mao B; Abdel-Razek O; Ramirez FD; Marbach JA; Dick A; Glover C; Russo JJ; Froeschl M; Labinaz M; Fernando SM; Hibbert B;
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):712-720. PubMed ID: 34382063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Karami M; Hemradj VV; Ouweneel DM; den Uil CA; Limpens J; Otterspoor LC; Vlaar AP; Lagrand WK; Henriques JPS
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32629772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
    Prosperi-Porta G; Motazedian P; Di Santo P; Jung RG; Parlow S; Abdel-Razek O; Simard T; Hutson J; Malhotra N; Fu A; Ramirez FD; Froeschl M; Mathew R; Hibbert B;
    J Cardiol; 2022 Oct; 80(4):358-364. PubMed ID: 35725945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
    Kelly J; Cheng J; Malloy R; Lupi K
    J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
    Jung RG; Di Santo P; Mathew R; Abdel-Razek O; Parlow S; Simard T; Marbach JA; Gillmore T; Mao B; Bernick J; Theriault-Lauzier P; Fu A; Lau L; Motazedian P; Russo JJ; Labinaz M; Hibbert B
    J Am Heart Assoc; 2021 Nov; 10(21):e021570. PubMed ID: 34713704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.